Global Cardiac Pacemaker Market Report and Forecast 2024-2032

Global Cardiac Pacemaker Market Outlook

The global cardiac pacemaker market size attained a value of about USD 4.91 billion in 2023. The market is further expected to grow at a CAGR of 3.1% to attain a value of USD 6.48 billion by 2032. The growth of the market can be attributed to the increasing prevalence of heart rhythm disorders, such as bradycardia and heart block.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Growing Demand in Ambulatory Surgical Centres to Augment the Cardiac Pacemaker Industry Growth

Based on end use, ambulatory surgical centres account for a significant share in the cardiac pacemaker industry. This can be attributed to its advanced consumer penetration and ease of care, especially in rural areas. In this case, ambulatory surgical centres have also proved to be a competent option. In addition, some of the high-impact market drivers for ambulatory surgical centres are projected to be the growing demand for reducing surgical and post-surgical spending and increasing prevalence of cardiovascular diseases.

The Asia-Pacific Region to Provide Enhanced Growth Opportunities to the Cardiac Pacemaker Industry

Region-wise, the Asia Pacific is expected to witness a robust growth over the forecast period owing to the increasing cases of cardiovascular disorders in the region. The growth is driven by the market expansion by major players and the presence of significant untapped opportunities. In addition, investment in the healthcare sector has gained momentum, especially in Japan, India, and China. These countries are increasingly focused on building comprehensive heart diagnostic and recovery healthcare facilities. These variables are anticipated to contribute to the market growth in the coming years.

Cardiac Pacemaker: Market Segmentation

A pacemaker is a tiny instrument in your chest that is mounted under the skin to help stabilize your heartbeat. It is used if you have an erratic heartbeat (arrhythmia), especially a sluggish one, to make the heartbeat more consistent. It takes a surgical operation to insert a pacemaker in your chest. After a heart attack, surgery, or drug overdose, they may be inserted temporarily to treat a sluggish pulse. Or, they may be permanently inserted to correct a sluggish or erratic pulse or to help treat cardiac disease in certain individuals.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

By type, the market is divided into:

• Implantable 
• External

Based on technology, the market is categorised into:

• Biventricular
• Single Chambered  
• Dual Chambered
• Others

Based on application, the market is divided into:

• Arrhythmias
• Congestive Heart Failure
• Others

On the basis of end use, the market is segmented into:

• Hospitals and Clinics
• Ambulatory Surgery Centres
• Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Growing Prevalence of Cardiovascular Diseases to Bolster the Growth of the Cardiac Pacemaker Industry

With the rise in people suffering from cardiovascular diseases, the cardiac pacemaker industry is at an all-time high. Citizens all over the world have adopted a sedentary lifestyle, which is leading to obesity, diabetes, and other lifestyle disorders. These lifestyle disorders turn into serious cardiovascular diseases such as high blood pressure, heart attack, and arrhythmia. The rise in poor lifestyle, combined with the technological advancements in the sector is likely to increase the demand for cardiac pacemaker. This is aiding the growth of the overall  market. Further, the reimbursement policies offered by the government has impacted the industry in a positive way. However, lack of understanding of cardiovascular diseases among the population in developed countries and the high medical costs may hamper the market growth.

Over the forecast period, rise in demand for advanced diagnostic facilities and the rapid technological advancements are expected to favour the industry growth. The worldwide increase in the sedentary population is expected to be a major trend in the coming years.

Key Industry Players in the Global Cardiac Pacemaker Market

The report gives a detailed analysis of the following key players in the global cardiac pacemaker market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

• Zoll Medical Corporation
• MicroPort Scientific Corporation
• OSCOR Inc.
• Osypka Medical GmbH
• Medtronic
• Abbott
• Boston Scientific Corporation
• BIOTRONIK
• LivaNova
• Pacetronix
• MEDICO
• Osypka Medical
• Lepu Medical Co ltd.

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report